Michael Thy Selected Research

Michael Thy Research Topics

3	COVID-19 10/2022 - 10/2020
3	Infections 01/2021 - 10/2020
2	Sepsis (Septicemia) 01/2023 - 01/2022
2	Critical Illness (Critically Ill) 12/2022 - 11/2022
1	Endocarditis 05/2024
1	Brain Injuries (Brain Injury) 10/2023
1	Seizures (Absence Seizure) 10/2023
1	Meningoencephalitis 10/2023
1	Inflammation (Inflammations) 01/2023
1	Tachycardia (Tachyarrhythmias) 01/2023
1	Breakthrough Infections 12/2022
1	Bacterial Infections (Bacterial Infection) 11/2022
1	Body Weight (Weight, Body) 11/2022
1	Meningitis 10/2022
1	Encephalitis (Encephalitis, Rasmussen) 10/2022
1	Autoimmune Diseases of the Nervous System 10/2022
1	Soft Tissue Infections 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	Coronavirus Infections 10/2020
1	Urinary Tract Infections (Urinary Tract Infection) 07/2020

2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 07/2020
1	Cefepime (Maxipime)FDA LinkGeneric 10/2023
1	Midazolam (Versed)FDA LinkGeneric 10/2023
1	Biomarkers (Surrogate Marker)IBA 10/2023
1	ElectrolytesIBA 01/2023
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 12/2022
1	Piperacillin FDA LinkGeneric 12/2022
1	Meropenem (Merrem)FDA LinkGeneric 11/2022
1	Monoclonal AntibodiesIBA 10/2022
1	Glycoproteins (Glycoprotein)IBA 10/2022
1	Ketamine FDA LinkGeneric 01/2021
1	Lopinavir FDA Link 10/2020
1	Ribavirin (Virazole)FDA LinkGeneric 10/2020
1	Chloroquine (Aralen)FDA LinkGeneric 10/2020
1	Antiviral Agents (Antivirals)IBA 10/2020
1	remdesivirIBA 10/2020
1	favipiravirIBA 10/2020
1	Ritonavir (Norvir)FDA Link 10/2020

3	Therapeutics 05/2024 - 10/2020
2	Critical Care (Surgical Intensive Care) 10/2023 - 10/2022
2	Continuous Renal Replacement Therapy 12/2022 - 11/2022
1	Induced Hypothermia 01/2023
1	Immunotherapy 10/2022
1	Personal Protective Equipment 01/2021